Cargando…
Treatment advances in systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the...
Autor principal: | Beukelman, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974570/ https://www.ncbi.nlm.nih.gov/pubmed/24765526 http://dx.doi.org/10.12703/P6-21 |
Ejemplares similares
-
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
por: Falvey, Sonja, et al.
Publicado: (2017) -
Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Mannion, Melissa L., et al.
Publicado: (2022) -
Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012) -
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami, Miho, et al.
Publicado: (2012) -
Advances in Musculoskeletal Imaging in Juvenile Idiopathic Arthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2022)